Actively Recruiting
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
Led by Mirador Therapeutics, Inc. · Updated on 2025-11-04
72
Participants Needed
1
Research Sites
64 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
First-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple doses of MT-201 in healthy participants.
CONDITIONS
Official Title
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female participant of nonchildbearing potential aged 19 to 55 years at consent
- Female participants must be postmenopausal or surgically sterile with documentation at least 6 months before dosing
- Male participants with female partners capable of pregnancy must use barrier contraception and avoid sperm donation
- Good general health
- Able to provide informed consent and follow study requirements
You will not qualify if you...
- History or presence of any significant organ system disease
- Abnormal lab tests, physical exam, or ECG deemed clinically significant by the investigator
- History of alcohol or drug abuse in the past 24 months
- Current or recent use of tobacco or nicotine products within 3 months prior to screening
- Use of investigational drugs or devices within 30 days before dosing
- Blood donation within 60 days or plasma donation within 14 days prior to dosing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mirador Clinical Department, San Diego, California 92121
San Diego, California, United States, 92121
Actively Recruiting
Research Team
T
Toll-Free Number
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here